You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Blood and bone marrow cancers

Blood and bone marrow cancers Products

A list of all our products on blood and bone marrow cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic selection

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
13 August 2025
Expected publication date:
5 November 2025
Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse B-cell lymphoma [ID6202]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
19 August 2025
Expected publication date:
TBC